Galenica AG
SIX:GALE

Watchlist Manager
Galenica AG Logo
Galenica AG
SIX:GALE
Watchlist
Price: 76.85 CHF -1.09% Market Closed
Market Cap: 3.8B CHF
Have any thoughts about
Galenica AG?
Write Note

Galenica AG
Intangible Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Galenica AG
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
Galenica AG
SIX:GALE
Intangible Assets
CHf1.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
No Stocks Found

Galenica AG
Glance View

Market Cap
3.8B CHF
Industry
Health Care

In the picturesque landscape of Switzerland, Galenica AG operates as a stalwart in the healthcare sector, seamlessly bridging the gap between pharmaceutical production and retail distribution. Born from a deep-rooted legacy in delivering health solutions, Galenica combines its prowess in logistics with an extensive network of pharmacies spread across the country. The magic of Galenica's operations lies in its unique dual structure. On one hand, it operates a robust logistics arm, supplying a wide array of medicines to healthcare providers, hospitals, and pharmacies. On the other hand, it runs its own retail pharmacy chains, such as Amavita and Sun Store, alongside an e-commerce platform, which make pharmaceutical care more accessible and customer-friendly for the Swiss populace. Galenica's profitability thrives on this diversified business model. By owning the supply chain from logistics to retail, the company maximizes efficiency and reduces costs, positioning itself as a leader in the Swiss pharmaceutical market. Revenue streams flow from wholesale distribution contracts, retail pharmacy sales, and a growing presence in digital health services. Furthermore, in its operations, Galenica integrates a customer-centric philosophy, leveraging data analytics to optimize stock management and personalize customer experiences—effectively enhancing earnings and customer loyalty. Through meticulous execution and strategic expansion, Galenica ensures that it remains an indispensable player in Switzerland's healthcare framework.

GALE Intrinsic Value
70.65 CHF
Overvaluation 8%
Intrinsic Value
Price

See Also

What is Galenica AG's Intangible Assets?
Intangible Assets
1.1B CHF

Based on the financial report for Jun 30, 2024, Galenica AG's Intangible Assets amounts to 1.1B CHF.

What is Galenica AG's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
6%

Over the last year, the Intangible Assets growth was 4%. The average annual Intangible Assets growth rates for Galenica AG have been 5% over the past three years , 6% over the past five years .

Back to Top